🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine whether amrubicin is safe and effe...
Status
Completed
Location
University of California San Diego
Start Date
2009-06-01
Trial ID
NCT00915083
Treatments Being Tested
The main objective is to compare the efficacy of tarlatamab with standard o...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2023-05-31
Trial ID
NCT05740566
Treatments Being Tested
This proposed trial will investigate the combination of amrubicin and carbo...
Status
Completed
Location
Northeast Arkansas Clinic
Start Date
2009-12
Trial ID
NCT01076504
Treatments Being Tested
To explore the overall response rate (ORR) per RECIST 1.1 as assessed by in...
Status
Unknown
Location
Wakayama Medical University
Start Date
2017-08-01
Trial ID
NCT03253068
Treatments Being Tested
The purpose of the study is to evaluate the incidence of cardiac toxicity o...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00380835
Treatments Being Tested
Doxorubicin has been an integral part of the treatment of women with breast...
Status
Completed
Location
NEA Baptist Clinic
Start Date
2009-12
Trial ID
NCT01033032
Treatments Being Tested
This study drug (Amrubicin) is believed to work by stopping the tumor cells...
Status
Completed
Location
Northwest Alabama Cancer Center
Start Date
2007-09-01
Trial ID
NCT00547651
Primary Objectives 1. To evaluate the Response Rate (RR) for amrubicin in ...
Status
Completed
Location
Santa Monica
Start Date
2011-09
Trial ID
NCT01259375
Treatments Being Tested
The purpose of the study is to evaluate the objective tumor response rate o...
Status
Completed
Location
Hematology Oncology Associates
Start Date
2006-11-01
Trial ID
NCT00375193
Treatments Being Tested
This study is designed to compare the efficacy and safety of I-DXd with tre...
Status
Recruiting
Location
Highlands Oncology Group
Start Date
2024-05-21
Trial ID
NCT06203210
Treatments Being Tested